Yield10 Bioscience Begins Field Testing of Novel Yield Trait Gene C3003 and Novel Trait Gene C3008 in Oilseed Crops
July 02 2018 - 8:30AM
Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new
technologies to create step-change improvements in crop yield to
enhance global food security, announced that its 2018 field test
program has begun based on the recent completion of planting at
study sites in Canada and the United States.
During the program, Yield10 is evaluating the novel
yield trait gene C3003 in Camelina and canola, and bulking up seed
in soybean at sites in Canada. In previous field tests, C3003 has
shown promising improvements in oilseed yield. Yield10 is also
evaluating for the first time the genome-edited trait C3008 in
Camelina in the United States. Following completion of these field
tests, the Company expects to harvest plants in the third quarter
and to report results of the study in the fourth quarter of 2018.
“We experienced difficult planting conditions on
the Canadian prairies due to a recent early season heat wave.
Having said that, our field test sites are now planted and our team
is executing a comprehensive set of studies to evaluate C3003 in
oilseed crops,” said Kristi Snell, Ph.D., Chief Science Officer of
Yield10 Bioscience. “We look forward to collecting field data that
will allow us to continue to optimize the use of C3003 to improve
seed yield in commercial oilseed crops, and to define the potential
market opportunity to address the unmet need for global food
security.”
Dr. Snell continued, “The evaluation of C3008 in
the field for the first time this year will mark an important
milestone in our research to develop and evaluate genome-edited
traits in oilseed crops. C3008 is one of a number of gene
targets, including the recently licensed C3007 gene from the
University of Missouri, that we plan to stack through multiple
genome edits as a new strategy to significantly increase oil
content and improve oil stability in oilseed crops. Evaluation of
C3008 in the field this year is intended to provide a baseline of
performance for comparison with future results using new plant
lines containing stacked edits.”
Background on Yield10’s 2018 Field Test
Program
The main focus of the Company’s 2018 Field Test
Program will be on the novel yield trait gene C3003 in Camelina,
canola and soybean. Yield10 is also conducting a field test of
Camelina lines that have been genome-edited to inactivate the C3008
gene as part of a new multi-trait approach to increase seed oil
content and to potentially improve oil stability.
A summary of Yield10’s 2018 Field Test Program:
- Camelina/C3003: Yield10 will test Gen 2.0 and
2.1 versions of C3003 in Camelina from seed produced during its
2017 field tests.
- Canola/C3003: Yield10 will test Gen 1.0
C3003 from seed produced in its 2017 field tests, and for the first
time will conduct a field test of Gen 2.0 C3003 in canola using
recently harvested greenhouse grown seed.
- Soybean/C3003: Yield10 will conduct
small-scale field work for the first time for Gen 1.0 and Gen 2.0
C3003 in soybean using recently harvested greenhouse grown
seed.
- Camelina/C3008: Yield10 will conduct field
tests with genome-edited C3008 lines for which the Company obtained
non-regulated status from USDA-APHIS in 2017.
For more information on Yield10’s 2018 Field Test
Program, please refer to the press release issued on April 23,
2018.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is focused on developing
new technologies to achieve step-change improvements in crop yield
to enhance global food security. Yield10 has an extensive track
record of innovation based around optimizing the flow of carbon in
living systems. Yield10 is leveraging its technology platforms and
unique knowledge base to design precise alterations to gene
activity and the flow of carbon in plants to produce higher yields
with lower inputs of land, water or fertilizer. Yield10 is
advancing several yield traits it has developed in crops such as
Camelina, canola, soybean and rice. Yield10 is headquartered in
Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon,
Canada.
For more information about the Company, please
visit www.yield10bio.com.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking
statements which are made pursuant to the safe harbor provisions of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. The
forward-looking statements in this release do not constitute
guarantees of future performance. Investors are cautioned that
statements in this press release which are not strictly historical,
including, without limitation, statements regarding the Company’s
intentions with regard to plans to continue field tests with
Camelina, canola and soybean in 2018, the results and outcome of
those tests, expectations with regard to the timing of reporting
results of the 2018 field tests, and weather conditions in the
regions where the Company is conducting its tests, constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience's filings with the Securities and Exchange Commission.
Yield10 assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
matters described herein.
Contacts:
Yield10 Bioscience:Lynne H. Brum,
(617) 682-4693, LBrum@yield10bio.com
Investor Relations:Amato and Partners,
LLCadmin@amatoandpartners.com
Media Inquiries: Eric FischgrundFischtank Marketing
and PReric@fischtankpr.com
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024